

<!DOCTYPE html>
<html lang="en-GB">
    <head>
        <title>Diagnosis and staging | NICEimpact lung cancer | Reviewing the impact of our guidance | Measuring the use of NICE guidance | Into practice | What we do | About | NICE</title>
        <!--[if lt IE 9]>
        <script src="https://cdn.nice.org.uk/global-nav/global-nav.ie8.min.js"></script>
        <![endif]-->
        <link href="https://fonts.googleapis.com/css?family=Lato:400,700,900" rel="stylesheet" type="text/css" />
<link href="/css/app.css" rel="stylesheet" type="text/css" />
<!--[if lt IE 9]>
<link href="/niceorg-client/ie8/css" rel="stylesheet" type="text/css" />
<![endif]-->
<!--[if lt IE 9]>
<script src="//cdn.nice.org.uk/V2/Scripts/html5shiv/html5shiv.js" type="text/javascript"></script>
<![endif]-->
<script src="/Themes/NICE.Bootstrap/scripts/jquery/jquery-1.12.4.min.js" type="text/javascript"></script>
<script src="/Themes/NICE.Bootstrap/scripts/head.combined-v1.10.8298.0.js" type="text/javascript"></script>






  <meta charset="utf-8" />
  <meta name="X-UA-Compatible" content="IE=edge,chrome=1" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta property="og:locale" content="en_GB" />
  <meta name="x-country" content="gb" />
  <meta name="DC.Title" content="Diagnosis and staging | NICEimpact lung cancer | Reviewing the impact of our guidance | Measuring the use of NICE guidance | Into practice | What we do | About | NICE" />
  <meta property="og:title" content="Diagnosis and staging" />
  <meta name="twitter:title" content="Diagnosis and staging" />
  <meta name="msapplication-TileColor" content="#f6f6f6" />
  <meta name="msapplication-TileImage" content="//cdn.nice.org.uk/V3/Content/nice/favicon-144.png" />
  <meta name="DC.Publisher" content="NICE" />
  <meta name="DC.Rights.Copyright" content="All content on this site is NICE copyright unless otherwise stated. You can download material for private research, study or in-house use only. Do not distribute or publish any material from this site without first obtaining NICE's permission. Where Crown copyright applies, see the Office of Public Sector Information (formerly HMSO) website for information." />
  <meta name="DC.Language" scheme="DCTERMS.ISO639-2T" content="eng" />
  <meta name="DC.Subject" scheme="eGMS.IPSV" content="Health, well-being and care" />
  <meta name="eGMS.accessibility" scheme="eGMS.WCAG10" content="Double-A" />
  <meta property="og:site_name" content="NICE" />
  <meta name="twitter:site" content="@NICEcomms" />
  <meta name="twitter:creator" content="@NICEcomms" />
  <meta name="twitter:card" content="summary" />
  <meta property="og:url" content="https://www.nice.org.uk/about/what-we-do/into-practice/measuring-the-use-of-nice-guidance/impact-of-our-guidance/niceimpact-lung-cancer/ch3-diagnosis-and-staging" />
  <meta property="og:type" content="article" />
  <meta property="article:author" content="https://www.facebook.com/NationalInstituteforHealthandCareExcellence" />
  <meta name="cid" content="117347" />
  <meta name="DC.Issued" scheme="DCTERMS.W3CDTF" content="2019-11-25" />
  <meta name="DC.Modified" scheme="DCTERMS.W3CDTF" content="2019-11-25" />
  <meta name="DC.Type" scheme="NICE.Publication.Types" content="CorporatePage"/>
  <meta name="description" content="The section of the NICE impact lung cancer report looking at the diagnosis and staging process of lung cancer care. " />
  <meta property="og:description" content="The section of the NICE impact lung cancer report looking at the diagnosis and staging process of lung cancer care. " />
  <meta name="twitter:description" content="The section of the NICE impact lung cancer report looking at the diagnosis and staging process of lung cancer care. " />



        <link rel="shortcut icon" href="//cdn.nice.org.uk/V3/Content/nice/favicon.ico" />
        <link rel="apple-touch-icon-precomposed" href="//cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
        <link rel="apple-touch-icon" href="//cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
        <link rel="apple-touch-icon-precomposed" sizes="120x120" href="//cdn.nice.org.uk/V3/Content/nice/favicon-120.png">
        <link rel="apple-touch-icon" sizes="120x120" href="//cdn.nice.org.uk/V3/Content/nice/favicon-120.png">
        <link rel="apple-touch-icon-precomposed" sizes="152x152" href="//cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
        <link rel="apple-touch-icon" sizes="152x152" href="//cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
            <link rel="canonical" href="https://www.nice.org.uk/about/what-we-do/into-practice/measuring-the-use-of-nice-guidance/impact-of-our-guidance/niceimpact-lung-cancer/ch3-diagnosis-and-staging" />
        <!--[if IE 6]><script>var ieVersion = 6;</script><![endif]-->
        <!--[if IE 7]><script>var ieVersion = 7;</script><![endif]-->
        <!--[if IE 8]><script>var ieVersion = 8;</script><![endif]-->


<script>     (function(h,o,t,j,a,r){         h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};         h._hjSettings={hjid:119167,hjsv:5};         a=o.getElementsByTagName('head')[0];         r=o.createElement('script');r.async=1;         r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;         a.appendChild(r);     })(window,document,'//static.hotjar.com/c/hotjar-','.js?sv='); </script><meta name="theme-color" content="#333"><!-- Start VWO Async Smartcode spa --> <script type='text/javascript'> window._vwo_code = window._vwo_code || (function(){ var account_id=257258, settings_tolerance=8000, library_tolerance=8000, use_existing_jquery=true, is_spa=0, hide_element='body', /* DO NOT EDIT BELOW THIS LINE */ f=false,d=document,code={use_existing_jquery:function(){return use_existing_jquery;},library_tolerance:function(){return library_tolerance;},finish:function(){if(!f){f=true;var a=d.getElementById('_vis_opt_path_hides');if(a)a.parentNode.removeChild(a);}},finished:function(){return f;},load:function(a){var b=d.createElement('script');b.src=a;b.type='text/javascript';b.innerText;b.onerror=function(){_vwo_code.finish();};d.getElementsByTagName('head')[0].appendChild(b);},init:function(){ settings_timer=setTimeout('_vwo_code.finish()',settings_tolerance);var a=d.createElement('style'),b=hide_element?hide_element+'{opacity:0 !important;filter:alpha(opacity=0) !important;background:none !important;}':'',h=d.getElementsByTagName('head')[0];a.setAttribute('id','_vis_opt_path_hides');a.setAttribute('type','text/css');if(a.styleSheet)a.styleSheet.cssText=b;else a.appendChild(d.createTextNode(b));h.appendChild(a);this.load('//dev.visualwebsiteoptimizer.com/j.php?a='+account_id+'&u='+encodeURIComponent(d.URL)+'&f='+(+is_spa)+'&r='+Math.random());return settings_timer; }};window._vwo_settings_timer = code.init(); return code; }()); </script> <!-- End VWO Async Smartcode --><link href="/Media/Default/css/default.css" rel="stylesheet" type="text/css" /><script src="/Media/Default/js/default.js" type="text/javascript"></script>

    </head>



<body data-spy="scroll" data-target=".aside-primary" class=" " >
<!-- Google Tag Manager -->
    <noscript>
        <iframe src="//www.googletagmanager.com/ns.html?id=GTM-M55QTQ"
                height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                    new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
                    j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
                        '//www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-M55QTQ');</script>
<!-- End Google Tag Manager -->


    <div id="global-nav-header"></div>



<div id="printpane"></div>
    <header class="container  ">
<div class="zone zone-breadcrumb">

<div class="widget-breadcrumb widget-sub-menu-widget widget">
    <div class="widget-content">

<div class="container">

<ul class="breadcrumb">
    <li><a href="/" data-track="mainbreadcrumb">Home</a><i class="divider icon-nice-chevron-right"></i></li>

    <li><a href="/about" data-track="mainbreadcrumb">About</a> <i class="divider icon-nice-chevron-right"></i></li>
    <li><a href="/about/what-we-do" data-track="mainbreadcrumb">What we do</a> <i class="divider icon-nice-chevron-right"></i></li>
    <li><a href="/about/what-we-do/into-practice" data-track="mainbreadcrumb">Into practice</a> <i class="divider icon-nice-chevron-right"></i></li>
    <li><a href="/about/what-we-do/into-practice/measuring-the-uptake-of-nice-guidance" data-track="mainbreadcrumb">Measuring the use of NICE guidance</a> <i class="divider icon-nice-chevron-right"></i></li>
    <li><a href="/about/what-we-do/into-practice/measuring-the-uptake-of-nice-guidance/impact-of-guidance" data-track="mainbreadcrumb">Reviewing the impact of our guidance</a> <i class="divider icon-nice-chevron-right"></i></li>
        <li class="active"><a href="/about/what-we-do/into-practice/measuring-the-use-of-nice-guidance/impact-of-our-guidance/niceimpact-lung-cancer" data-track="mainbreadcrumb">NICEimpact lung cancer</a></li>
</ul>


    <h1 id="content-start">Diagnosis and staging</h1>




</div>
    </div>
  </div></div>            </header>
<div id="toTop"><i aria-hidden="true" class="icon-nice-chevron-up"></i></div>
<div class="layout ">
    <div class="">
                        <div class="zone zone-content"><div class="page-content corporate-content">
  <div class="grid">
<div data-g="12 md:7">
<p class="lead">Minimising the number of steps in a diagnosis and staging pathway and completing them efficiently will reduce delays in care. NICE&rsquo;s&nbsp;<a href="https://www.nice.org.uk/guidance/ng122">guideline on lung cancer</a> makes a number of recommendations that optimise the diagnostic pathway and allow flexibility for managing a range of people that may present with symptoms of lung cancer.</p>
</div>
</div>
<div class="grid">
<div data-g="12 md:7">
<h2>Pathological confirmation and staging</h2>
<p>NICE&rsquo;s&nbsp;<a href="https://www.nice.org.uk/guidance/ng122">guideline on lung cancer</a> and&nbsp;<a href="https://www.nice.org.uk/guidance/qs17">quality standard on lung cancer</a> state that, when taking samples in people with suspected lung cancer, they should be adequate to permit pathological diagnosis, including tumour subtyping and assessment of predictive markers. A predictive cancer marker is anything present in or produced by cancer cells or other cells of the body in response to cancer. They can provide information on how aggressive the cancer is and whether it could be treated with a targeted therapy. Obtaining a pathological diagnosis and assessment of predictive markers ensures that the most appropriate treatment regimen is offered.</p>
<p>Data from the Royal College of Physicians&rsquo;&nbsp;<a href="https://www.rcplondon.ac.uk/projects/national-lung-cancer-audit">National Lung Cancer Audit</a> (NLCA) show that pathological confirmation rates in all stages of lung cancer dropped in 2014. They have since shown improvement but still remain below the 2013 rate.</p>
</div>
<div data-g="12 md:5">
<div class="panel ml--e">
<p>Tumours grow when, instead of repairing or self-destructing, mutated cells continue to multiply. Samples of the cancerous cells can be biopsied and used for pathological analysis to provide detail on the type of mutation. This is known as pathological diagnosis.</p>
<p>Cancer stage refers to how much the cancer has developed by growing and spreading. Stage 1 lung cancer is small and hasn&rsquo;t spread, while stage 4 has usually spread to the other lung, or other parts of the body such as the liver, bones or brain. Accurate assessment of stage often involves various scans and other tests, such as an endobronchial ultrasound, a technique used to visualise the airway.</p>
</div>
</div>
</div>
<!-- Chart to go in here -->
<div class="grid">
<div data-g="12">
<div class="infogram-embed" data-id="_/4Cs1rp0T1Trf8l62UQCr" data-type="interactive" data-title="Proportion of lung cancers pathologically confirmed"></div>
<script>// <![CDATA[
!function(e,i,n,s){var t="InfogramEmbeds",d=e.getElementsByTagName("script")[0];if(window[t]&&window[t].initialized)window[t].process&&window[t].process();else if(!e.getElementById(n)){var o=e.createElement("script");o.async=1,o.id=n,o.src="https://e.infogram.com/js/dist/embed-loader-min.js",d.parentNode.insertBefore(o,d)}}(document,0,"infogram-async");
// ]]></script>
</div>
</div>
<div class="grid">
<div data-g="12 md:7">
<p>The latest report from the NLCA, published in May 2019, reports pathological confirmation rates in people with early stage lung cancer only. This is because some clinicians feel that people who have late stage lung cancer are unlikely to tolerate or benefit from an invasive biopsy. Similarly, NICE recommends that pathological diagnosis should only be performed without unacceptable risk to the person. In 2017, the pathological confirmation rate for people with stage 1 to 2 lung cancer who had a performance status of 0 to 1 was 89% in England.</p>
<p>To enable increased pathological diagnosis rates, the&nbsp;<a href="https://www.england.nhs.uk/long-term-plan/">NHS Long Term Plan</a>&nbsp;details plans to increase capacity in diagnostic services by investing new equipment and staff.</p>
</div>
<div data-g="12 md:5">
<div class="panel ml--e mt--e">
<p>Performance status (PS) is a measure of how well a person is able to carry on ordinary daily activities while living with cancer and provides an estimate of what treatments a person may be able to tolerate. Someone whose PS is 0 or 1 can carry out most of their usual daily activities without help, whereas someone with a PS of 4 is usually confined to a bed or chair and needs help with all daily activities.</p>
</div>
</div>
</div>
<div class="grid">
<div data-g="12 md:7">
<h2>Multidisciplinary team meetings</h2>
<p>Multidisciplinary team meetings are key to the effective diagnosis and staging of lung cancer. Bringing together a breadth of experience and knowledge from a range of healthcare professionals to form a multidisciplinary team allows for rapid decisions around patient assessment and appropriate treatment. Lung cancer multidisciplinary teams will often include a chest physician, radiologist, pathologist, specialist nurse, oncologist, surgeon and members of a palliative care team.</p>
</div>
</div>
<div class="grid">
<div data-g="12 md:1" class="pt--d"><img class="show-md" alt="" src="https://www.nice.org.uk/Media/Default/About/what-we-do/Into-practice/measuring-uptake/lung-cancer-impact-report/asterisk.png" style="height: 65px;" /></div>
<div data-g="12 md:11">
<p><span class="h4">Recent years have seen an increase in the proportion of people with lung cancer that are being discussed at multidisciplinary team meetings</span></p>
</div>
</div>
<div class="grid grid--loose">
<div data-g="12 md:7">
<p>NICE recommends that the care of all people with suspected lung cancer should be discussed at a lung cancer multidisciplinary team meeting. Data from the NLCA show that, in 2017, 87% of people with lung cancer were discussed at an multidisciplinary team meeting. This is an increase from 82% in the 2015 audit.</p>
</div>
</div>
<hr />
<div class="clearfix nav-links hide-print">
<div class="left">
<p><a href="https://www.nice.org.uk/about/what-we-do/into-practice/measuring-the-use-of-nice-guidance/impact-of-our-guidance/niceimpact-lung-cancer " class="btn">Back to menu</a></p>
</div>
<div class="right">
<p><a href="https://www.nice.org.uk/about/what-we-do/into-practice/measuring-the-use-of-nice-guidance/impact-of-our-guidance/niceimpact-lung-cancer/ch4-treatment-for-lung-cancer" class="btn">Next page: treatment</a></p>
</div>
</div>


</div></div>            </div>
    </div>
<!-- layout -->


    <!--[if lt IE 9]>
<script src="//cdnjs.cloudflare.com/ajax/libs/respond.js/1.4.2/respond.min.js" type="text/javascript"></script>
<![endif]-->
<script src="//cdn.nice.org.uk/V2/Scripts/twitter.bootstrap.min.js" type="text/javascript"></script>
<script src="//cdn.nice.org.uk/V2/Scripts/NICE.bootstrap.min.js" type="text/javascript"></script>
<script type="text/javascript"></script>
<script src="/Modules/Orchard.Resources/scripts/history.min.js" type="text/javascript"></script>
<script src="//cdn.nice.org.uk/V3/Scripts/nice/NICE.EventTracking.js" type="text/javascript"></script>
<script src="/Themes/NICE.Bootstrap/scripts/niceorg/NICE.TopScroll.js" type="text/javascript"></script>
<script src="/Themes/NICE.Bootstrap/scripts/foot.combined-v1.10.8298.0.js" type="text/javascript"></script>


    <script>
        var global_nav_config = {
            service: "",
            header: {
                skipLinkId: "content-start",
                search: {
                    url: "/search",
                    autocomplete: "/autocomplete?ajax=ajax",
                    query: ""
                },
                auth: {
                    environment: "live"
                }
            },
            footer: true
        };
    </script>

    <script src="http://localhost:8080/global-nav.js" defer></script>

    <script type="text/javascript">
        $(document).ajaxSend(function (event, jqxhr, settings) {
            if (settings.url.indexOf("?") >= 0) {
                settings.url = settings.url + "&ajax=ajax";
            } else {
                settings.url = settings.url + "?ajax=ajax";
            }
        })
        if ('ontouchstart' in document.documentElement) {
            $('body').addClass('touch-screen-device');
        } else {
            $('body').addClass('non-touch-screen-device');
        }
    </script>
    <div id="global-nav-footer" data="blah"></div>
</body>
</html>
